LGT Fund Management Co Ltd. lifted its holdings in shares of The Chemours Company (NYSE:CC – Free Report) by 12.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 215,481 shares of the specialty chemicals company’s stock after purchasing an additional 23,553 shares during the quarter. LGT Fund Management Co Ltd. owned about 0.14% of Chemours worth $3,642,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Blue Trust Inc. boosted its holdings in shares of Chemours by 166.9% during the third quarter. Blue Trust Inc. now owns 1,169 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 731 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Chemours by 99.7% during the fourth quarter. GAMMA Investing LLC now owns 1,532 shares of the specialty chemicals company’s stock worth $26,000 after purchasing an additional 765 shares during the last quarter. Truvestments Capital LLC acquired a new stake in shares of Chemours during the third quarter worth $35,000. Brooklyn Investment Group acquired a new stake in shares of Chemours during the third quarter worth $37,000. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Chemours during the third quarter worth $75,000. Institutional investors and hedge funds own 76.26% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts have recently issued reports on CC shares. Truist Financial started coverage on Chemours in a report on Tuesday, January 28th. They set a “buy” rating and a $27.00 price objective on the stock. BMO Capital Markets reduced their target price on Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a report on Wednesday, February 19th. The Goldman Sachs Group reduced their target price on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a report on Tuesday, January 7th. Royal Bank of Canada reiterated an “outperform” rating and issued a $25.00 target price on shares of Chemours in a report on Thursday, December 12th. Finally, Barclays reduced their target price on Chemours from $23.00 to $19.00 and set an “equal weight” rating on the stock in a report on Monday, February 24th. Five analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $23.11.
Chemours Trading Down 1.6 %
NYSE:CC opened at $14.95 on Monday. The business’s 50-day moving average is $17.86 and its two-hundred day moving average is $18.83. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92. The Chemours Company has a 12 month low of $14.65 and a 12 month high of $29.21. The firm has a market capitalization of $2.23 billion, a PE ratio of 26.23 and a beta of 1.81.
Chemours (NYSE:CC – Get Free Report) last released its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The company had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.37 billion. Research analysts predict that The Chemours Company will post 2.03 earnings per share for the current fiscal year.
Chemours Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 28th will be given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 6.69%. The ex-dividend date is Friday, February 28th. Chemours’s dividend payout ratio (DPR) is presently 175.44%.
About Chemours
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.
Further Reading
- Five stocks we like better than Chemours
- Why Invest in 5G? How to Invest in 5G Stocks
- Chaos and Cash: Finding Opportunity in Volatility
- What is a penny stock? A comprehensive guide
- Realty Income: An Anchor in Volatile Markets
- Insider Trades May Not Tell You What You Think
- Autodesk Designs Value for Investors: Uptrend Set to Continue
Want to see what other hedge funds are holding CC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Chemours Company (NYSE:CC – Free Report).
Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.